Table 1.
Patient demographics and clinical results
| Patient no. | Sex | Age | Diagnosis | Wound preparation period | Wound area after wound preparation (cm 2 ) | Wound area after the first set of extended NPWT assisted dermatotraction (cm 2 ) | Extended NPWT assisted dermatotraction cycle | Extended NPWT assisted dermatotraction period | Final results | Complications requiring surgical interventions | Follow-up duration (months) | Co-morbidities |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Male |
62 |
Necrotizing fasciitis, thigh and lower leg, Lt. |
6 |
500 (50 × 10, thigh) 455 (35 × 13, lower leg) 80 (10 × 8, posterior calf) |
0 (thigh, lower leg) 25 × 35 (posterior calf) |
2 |
5 |
Direct closure, STSG (posterior calf) |
None |
59 |
None |
| 2 |
Male |
59 |
Necrotizing fasciitis, thigh, Rt. |
46 |
825 (55 × 15) |
0 |
4 |
14 |
Direct closure |
None |
4 |
DM, Pn, TB, Liver abscess |
| 3 |
Female |
72 |
Necrotizing fasciitis, buttock and thigh, Lt. |
22 (thigh), 47 (buttock) |
400 (40 × 10, thigh) 675 (45 × 15, buttock) |
0 |
4 (thigh) 3 (buttock) |
12 (thigh) 10 (buttock) |
Direct closure |
None |
23 |
DM, CVA |
| 4 |
Male |
40 |
Necrotizing fasciitis, chest wall, Lt. |
40 |
1000 (50 × 20) |
0 |
14 |
40 |
Direct closure |
None |
27 |
HBV |
| 5 |
Male |
43 |
Necrotizing fasciitis, chest wall, Lt. |
28 |
160 (20 × 8) |
35 (7 × 5) |
4 |
14 |
Latissimus dorsi musculocutaneous flap coverage |
None |
2 |
DM |
| 6 |
Male |
40 |
Fournier’s gangrene |
22 |
450 (30 × 15) |
0 |
7 |
23 |
Direct closure |
None |
2 |
TB |
| 7 |
Male |
53 |
Fournier’s gangrene |
44 |
300 (20 × 15) |
50 (10 × 5) |
6 |
15 |
Direct closure |
Partial wound dehiscence - secondary closure |
24 |
DM, HTN, Paraplegia |
| 8 |
Male |
59 |
Fournier’s gangrene |
39 |
500 (25 × 20) |
150 (15 × 10) |
3 |
6 |
Direct closure, STSG |
Partial wound dehiscence - secondary closure with STSG |
6 |
DM, HTN, CRF |
| Mean | 54 | 32.4 | 658.12 | 29.37 | 5.4 | 16 | 18.3 |
Abbreviations: DM diabetes mellitus, HTN hypertension, Pn pneumonia, TB tuberculosis, CVA cerebrovascular accident, CRF chronic renal failure, HBV hepatitis B, STSG split-thickness skin grafts.